PHPY303 XIAO Lecture 10 Metabolic Disorders March_31_2025 (1) Flashcards

1
Q

What are the major sources of energy for the human body?

A

Glucose and fatty acids

These are crucial for maintaining energy homeostasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is disrupted energy/glucose/lipid homeostasis associated with?

A

Diseases such as diabetes, obesity, dyslipidemia, metabolic syndrome, cardiovascular disease, and fatty liver

These conditions arise due to the failure of metabolic regulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Type I diabetes mellitus (T1DM)?

A

An autoimmune disease characterized by pancreatic islet beta-cell destruction leading to absolute insulin deficiency

T1DM results in the body being unable to produce insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Type II diabetes mellitus (T2DM)?

A

A condition marked by insulin resistance and relative insulin deficiency due to beta-cell dysfunction

T2DM often involves a failure of beta-cells to compensate for insulin resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the Disposition Index (DI)?

A

DI = Insulin sensitivity x Insulin secretion

It reflects the relationship between insulin secretion and sensitivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

True or False: Insulin resistance is accompanied by a decrease in insulin secretion.

A

False

Insulin resistance is typically accompanied by an increase in insulin secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are key treatment strategies for Type II diabetes?

A

Medications that improve glucose homeostasis, including:
* Insulin sensitizers
* Insulin secretagogues
* Alpha-glucosidase inhibitors
* SGLT2 inhibitors

These treatments aim to restore glucose balance in the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the formula for calculating Body Mass Index (BMI)?

A

BMI = (weight in kg) / (height in m)^2

This formula helps categorize individuals based on their weight relative to height.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What BMI range is considered as obesity?

A

≥30

Obesity is a significant health issue affecting a large proportion of the population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a common monogenic cause of obesity?

A

Mutations in leptin or melanocortin receptor 4 (MC4R) gene

These genetic factors can lead to rare forms of obesity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What lifestyle changes are key strategies for preventing obesity?

A

Healthy food options and increasing physical activity

These changes can significantly impact weight management.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the types of bariatric surgery mentioned?

A
  • Roux-en-Y gastric bypass (RYGB)
  • Sleeve gastrectomy (SG)
  • Adjustable gastric banding (AGB)
  • Biliopancreatic diversion with duodenal switch (BPD/DS)

These surgeries are effective for severe obesity treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the estimated weight reduction after bariatric surgery at 1-2 years?

A

25-30%

This substantial weight loss can lead to resolution of obesity-related complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are GLP-1 receptor agonists used for?

A

They are used to reduce appetite and energy intake

These drugs are effective for weight management and diabetes treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the role of tirzepatide?

A

A once-weekly injectable peptide that acts as a GLP-1/GIP receptor dual agonist

It has shown greater weight reduction compared to GLP-1 receptor agonists alone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fill in the blank: The cornerstone of weight management is _______.

A

Lifestyle intervention (diet and exercise)

This approach is essential for long-term success in obesity treatment.

17
Q

What is the weight reduction percentage associated with GLP-1 receptor agonist in clinical trials?

A

~20%

Referenced in Jastreboff et al. NEJM 2022

18
Q

What type of agonist is Tirzepatide?

A

GLP-1/GIP receptor dual agonist

More weight reduction than GLP-1R agonist alone

19
Q

What is the main benefit of exercise in relation to obesity?

A

Long-lasting benefits in weight management

Lifestyle remains the cornerstone of battling obesity

20
Q

What is the focus of the SURMOUNT-4 randomized clinical trial?

A

Maintenance of weight reduction in adults with obesity using Tirzepatide

Published in JAMA 2024

21
Q

What happens to weight after stopping GLP-1 receptor agonists?

A

Weight rebound

Indicates the need for continued treatment for sustained results

22
Q

Which GLP-1 receptor agonist was compared with placebo for weight reduction in a 2022 study?

A

Once-Weekly Semaglutide

Jastreboff et al. N Engl J Med 2022

23
Q

What is the significance of restoring homeostasis in metabolic disorders?

A

Prevention and treatment of diabetes and obesity

Key to addressing disrupted glucose/energy/lipid homeostasis

24
Q

What is the title of the study by JP Wilding et al. related to liraglutide?

A

Liraglutide and Body Weight

N Engl J Med 2021

25
Fill in the blank: Disrupted glucose/energy/lipid homeostasis leads to _______.
Metabolic disorders
26
True or False: Oral Semaglutide has been studied in relation to obesity management.
True ## Footnote Mentioned in The Lancet 2023
27
What is the primary focus of lifestyle interventions in obesity management?
Weight management ## Footnote Lifestyle remains crucial for effective obesity treatment